Olanzapine reduces urge to drink after drinking cues and a priming dose of alcohol

Psychopharmacology

Volumn 155, Issue 1, 2001, Pages 27-34

  Hutchison, K E ^a   Swift, R ^a   Rohsenow, D J ^a   Monti, P M ^a   Davidson, D ^a   Almeida, A ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Alcohol; Craving; Dopamine; Olanzapine; Stimulation; Urge

Indexed keywords

DOPAMINE 2 RECEPTOR BLOCKING AGENT; HALOPERIDOL; OLANZAPINE; PLACEBO; SEROTONIN 2 ANTAGONIST;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; ASSOCIATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRINKING BEHAVIOR; DRUG EFFECT; FEMALE; HUMAN; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; WITHDRAWAL SYNDROME;

ADULT; ALCOHOL DRINKING; ANALYSIS OF VARIANCE; BEHAVIOR; BENZODIAZEPINES; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CUES; ETHANOL; FEMALE; HUMANS; MALE; PIRENZEPINE; SEROTONIN UPTAKE INHIBITORS;

EID: 0035075993     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130000629     Document Type: Article

References (36)

1. Olanzapine versus placebo: Results of a double-blind, fixed-dose olanzapine trial
2. Naltrexone reverses ethanol-induced dopamine release in the nucleus accumbens in awake, freely moving rats
3. Haloperidol antagonism of cue-elicited cocaine craving
4. Development and initial validation of a measure of drinking urges in abstinent alcoholics
5. Effects of naltrexone on alcohol self-administration in heavy drinkers
6. Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer
7. Distraction does not impair memory during intoxication: Support for the attention-allocation model
8. Carbamazepine and cocaine-cue reactivity
9. Ritanserin in the treatment of alcohol dependence - A multi-center clinical trial
10. Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future dependence
11. Pharmacotherapies for alcohol problems: A review of research with focus on developments since 1991
12. Current concepts of ethanol dependence
13. Development and validation of the biphasic alcohol effects scale
14. Ritanserin reduces abuse of alcohol, cocaine, and fentanyl in rats
15. Effect of haloperidol on measures of craving and impaired control in alcoholic subjects
16. Reactivity of alcoholics and nonalcoholics to drinking cues
17. Cue exposure with coping skills treatment for male alcoholics: A preliminary investigation
18. Naltrexone's effects on cue-elicited craving among alcoholics in treatment
19. Toward bridging the gap between biological, psychobiological, and psychosocial models of alcohol craving
20. Selective reduction by the 5-HT antagonist amperozide of alcohol preference induced in rats by systemic cyanamide
21. Irreversible suppression of alcohol drinking in cyanamide-treated rats after sustained delivery of the 5-HT2 antagonist amperozide
22. Experience of a "slip" among alcoholics treated with naltrexone or placebo
23. Using cue reactivity to screen medications for cocaine abuse: A test of amantadine hydrochloride
24. Naltrexone's effects on reactivity to alcohol cues among alcoholic men
25. Neurobiology of alcohol abuse
26. Development of the alcohol use disorders screening test (AUDIT). WHO collaborative project on early detection of persons with harmful consumption. II
27. Tiapride in the long-term management of alcoholics of anxious or depressive temperament
28. Tiapride in the prevention of relapse in recently detoxified alcoholics
29. Alcohol dependence syndrome: Measurement and validation
30. Convergent validity: An approach to increasing confidence in treatment outcome conclusions with alcohol and drug abusers
31. Conduct disorder and comorbidity
32. Naltrexone-induced alterations in human ethanol intoxication
33. A double-blind, controlled comparison of the novel antipsychotic olanzapine versus haloperidol or placebo on anxious and depressive symptoms accompanying schizophrenia
34. Effect of naltrexone on alcohol "high" in alcoholics
35. Total body water and blood alcohol levels: Updating the fundamentals
36. Development and validation of brief measures of positive and negative affect: The PANAS scales